 Studies concanavalin nonobese diabetic mice Prevention insulin-dependent diabetes Con vivo development insulin-dependent diabetes IDDM nonobese diabetic mice experimental day Con A-treated animals IDDM cohort controls saline colony controls Treatment initial course Con dose micrograms/g i.p sterile saline day deaths Con group treatment day animals booster doses experimental days single animal Con group IDDM day injection days Histological examination peri-islet lymphocytosis islet infiltration Con group control animals peri-islet islet infiltrates One-week Con treatment vitro responses spleen cells allogeneic lymphocytes treatment frequency blast-sized cells vivo ratio splenocytes polyclonal cell activation Con protection autoimmune diabetes nonobese diabetic mice concomitant phenotypic morphologic lymphocyte changes